Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 265, Issue 3, 2015, Pages 227-232

  Bumb, Jan Malte ^a   Aksay, Suna Su ^a   Janke, Christoph ^a   Kranaster, Laura ^a   Geisel, Olga ^b   Gass, Peter ^a   Hellweg, Rainer ^b   Sartorius, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BDNF; Depression; Electroconvulsive therapy; Neurotransmitter; Seizure quality

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BRAIN DERIVED NEUROTROPHIC FACTOR BLOOD LEVEL; BRAIN FUNCTION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ELECTROCONVULSIVE THERAPY UNIT; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCORING SYSTEM; SEIZURE; SYMPATHETIC FUNCTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; AGE; AGED; ANALYSIS OF VARIANCE; BLOOD; DEPRESSIVE DISORDER, MAJOR; PROCEDURES; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS; TIME;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 84925486164     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0543-3     Document Type: Article

References (41)

1. Abrams R (2002) Electroconvulsive therapy, 4th edn. Oxford University Press, Oxford
2. Meduna L (1935) Versuche über die biologische Beeinflussung des Ablaufs der Schizophrenie. Z Ges Neural Psychiat 152:78–94
3. Cerletti U, Bini L (1938) Un nuevo metodo di shockterapie “L’elettroshock”. Boll Acad Med Roma 64:136–138
4. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J (1993) EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 34(5):321–330
5. Roemer RA, Shagass C, Dubin W, Jaffe R, Katz R (1990) Relationship between pretreatment electroencephalographic coherence measures and subsequent response to electroconvulsive therapy: a preliminary study. Neuropsychobiology 24(3):121–124
6. Swartz CM (1996) Disconnection of electroencephalographic, motoric, and cardiac evidence of ECT seizure. Convuls Ther 12(1):25–30
7. Kranaster L, Hoyer C, Janke C, Sartorius A (2013) Bispectral index monitoring and seizure quality optimization in electroconvulsive therapy. Pharmacopsychiatry 46(4):147–150. doi:10.1055/s-0032-1331748
8. Bundy BD, Hewer W, Andres FJ, Gass P, Sartorius A (2010) Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy. J Clin Psychiatry 71(6):775–777. doi:10.4088/JCP.08m04971gre
9. Hoyer C, Kranaster L, Janke C, Sartorius A (2014) Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 264(3):255–261. doi:10.1007/s00406-013-0420-5
10. Aksay SS, Bumb JM, Janke C, Hoyer C, Kranaster L, Sartorius A (2014) New evidence for seizure quality improvement by hyperoxia and mild hypocapnia. J ECT. doi:10.1097/YCT.0000000000000109
11. Wahlund B, von Rosen D (2003) ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology 28(Suppl 1):S21–S26. doi:10.1038/sj.npp.1300135
12. Merkl A, Heuser I, Bajbouj M (2009) Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp Neurol 219(1):20–26. doi:10.1016/j.expneurol.2009.04.027
13. Henn F, Vollmayr B, Sartorius A (2004) Mechanisms of depression: the role of neurogenesis. Drug Discov Today Dis Mech 1(4):407–411
14. Duman RS, Charney DS (1999) Cell atrophy and loss in major depression. Biol Psychiatry 45(9):1083–1084
15. Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7(Suppl 1):S29–S34. doi:10.1038/sj.mp.4001016
16. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109(2):143–148
17. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM (2013) Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N = 9484). Mol Psychiatry. doi:10.1038/mp.2013.105
18. Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45(8):995–1004. doi:10.1016/j.jpsychires.2011.03.002
19. Brunoni AR, Lopes M, Fregni F (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol Off Sci J Collegium Internationale Neuropsychopharmacologicum 11(8):1169–1180. doi:10.1017/S1461145708009309
20. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, Riva MA, Marchina E, Pasqualetti P, Perez J, Gennarelli M (2006) Electroconvulsive Therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 16(8):620–624. doi:10.1016/j.euroneuro.2006.04.010
21. Okamoto T, Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Inoue Y, Ueda N, Nakamura J (2008) Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 32(5):1185–1190. doi:10.1016/j.pnpbp.2008.02.009
22. Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, Zanello S, Massimetti E, Origlia N, Domenici L, Marazziti D, Dell’Osso L (2009) Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol 19(5):349–355. doi:10.1016/j.euroneuro.2009.01.002
23. Fernandes B, Gama CS, Massuda R, Torres M, Camargo D, Kunz M, Belmonte-de-Abreu PS, Kapczinski F, de Almeida Fleck MP, Ines Lobato M (2009) Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett 453(3):195–198. doi:10.1016/j.neulet.2009.02.032
24. Taylor SM (2008) Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT 24(2):160–165. doi:10.1097/YCT.0b013e3181571ad0
25. Association AP (2000) Diagnostic and statistical manual of mental disorders (DSM-IV-TR), text revision, 4th edn. American Psychiatric Association, Washington, DC
26. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
27. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
28. Ziegenhorn AA, Schulte-Herbruggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, Lang UE, Steinhagen-Thiessen E, Schaub RT, Hellweg R (2007) Serum neurotrophins—a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 28(9):1436–1445. doi:10.1016/j.neurobiolaging.2006.06.011
29. Deuschle M, Gilles M, Scharnholz B, Lederbogen F, Lang UE, Hellweg R (2013) Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment. Pharmacopsychiatry 46(2):54–58. doi:10.1055/s-0032-1321908
30. Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA (2014) BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry. doi:10.3109/15622975.2014.892633
31. Gronli O, Stensland GO, Wynn R, Olstad R (2009) Neurotrophic factors in serum following ECT: a pilot study. World J Biol Psychiatry 10(4):295–301. doi:10.3109/15622970701586323
32. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42(6):270–276. doi:10.1055/s-0029-1224162
33. Gass P, Riva MA (2007) CREB, neurogenesis and depression. BioEssays: news and reviews in molecular, cellular and developmental biology 29(10):957–961. doi:10.1002/bies.20658
34. Inta D, Lima-Ojeda JM, Lau T, Tang W, Dormann C, Sprengel R, Schloss P, Sartorius A, Meyer-Lindenberg A, Gass P (2013) Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS one 8(7):e69869. doi:10.1371/journal.pone.0069869
35. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553–1561
36. Poduslo JF, Curran GL (1996) Permeability at the blood–brain and blood–nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3. Brain Res Mol Brain Research 36(2):280–286
37. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23(34):10841–10851
38. Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S (2013) Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharmacol 23(10):1199–1207. doi:10.1016/j.euroneuro.2012.10.012
39. Dale GL (1997) Platelet kinetics. Curr Opin Hematol 4(5):330–334
40. Lommatzsch M, Quarcoo D, Schulte-Herbruggen O, Weber H, Virchow JC, Renz H, Braun A (2005) Neurotrophins in murine viscera: a dynamic pattern from birth to adulthood. Int J Dev Neurosci 23(6):495–500. doi:10.1016/j.ijdevneu.2005.05.009
41. Nockher WA, Renz H (2005) Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation. Clin Chim Acta 352(1–2):49–74. doi:10.1016/j.cccn.2004.10.002